Retatrutide is a triple hormone receptor agonist that targets GLP-1, GIP, and glucagon receptors
delivery, efgartigimod was reformulated so as to be given together with recombinant human hyaluronidase PH20
The injection is given in the arm, intramuscularly
Used Across Model Systems : Employed in cell-based assays, animal models, and clinical research settings to explore satiety-related measures, changes in body weight, metabolic markers, and hormonal interactions
These murine models were then divided into two groups, where one was presented with placebo and the other with BPC-157 daily for up to 14 days
[PubMed] [Google Scholar] 32.Huang N.F., Lam A., Fang Q., Sievers R.E., Li S., Lee R.J